Sort by
Refine Your Search
-
, and computational method development, unified by a common effort to translate these approaches into tools that change how patients are diagnosed and treated. One arm of the lab focuses on pushing
-
, including opportunities to develop new scientific directions, design and execute experiments, analyze and interpret data, prepare manuscripts, present research, and contribute to collaborations within
-
extractive diagnostics for reacting flows, gas-phase species, aerosols, catalysts, and carbon products. Interpret experimental results using chemical-kinetic and reacting-flow models, including assessment
-
, respiratory waveforms, heart rate, blood pressure trends, and other bedside monitoring signals. The goal of this work is to develop, validate, and translate computational methods that extract clinically
-
availability, and internal equity. Pay Range: $79,056 - $80,212 The Endocrine Oncology Lab is seeking an ambitious and meticulous postdoctoral scholar who cares deeply about advancing translational science and
-
paired with computational biology and machine learning to develop predictive AI models of how cells interpret and respond to the surrounding extracellular matrix. Required Qualifications: We are looking
-
hypothesis driven mechanistic projects in vitamin A transport and transcriptional networks, integrating classic retinoid biology with lipid metabolism, inflammation, and translational human disease studies
-
collaborative research ecosystem spanning the Stanford Translational AI (STAI) Lab(link is external) , the NeuroAI Lab(link is external) , the Stanford Wu Tsai Neurosceince Institute(link is external) , and the
-
rigorous research and clinically oriented translation, we develop evidence-based innovations to improve diagnosis, prognosis, and treatment, with the ultimate goal of improving outcomes for individuals
-
Lab The Kalbasi Lab is a basic and translational immunology laboratory that merges a curiosity for the fundamental principles governing anti-tumor immunity with a drive to design novel immunotherapeutic